Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-11-12
2009-06-09
Carlson, Karen Cochrane (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C435S013000, C435S069600, C536S023400
Reexamination Certificate
active
07544660
ABSTRACT:
Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
REFERENCES:
patent: 5364771 (1994-11-01), Lollar et al.
patent: 0808901 (1997-11-01), None
patent: WO 97/03195 (1997-01-01), None
patent: WO 87/07144 (1997-12-01), None
NCBI Sequence Viewer v2.0, (2006) AAA52484 factor VIII, www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?dbprotein&val=182803.
Liu et al. (2000) “Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure”, Blood, vol. 96, No. 3, pp. 979-987.
Pemberton et al. (1997) “A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin”, Blood, vol. 89, No. 7, pp. 2413-2421.
Toole et al. (1984) Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature,, vol. 312, No. 5992, pp. 342-347.
Thompson et al. (1997) Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation, Blood, vol. 90, No. 5, pp. 1902-1910.
NCBI (2008, updated) http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=182803, pp. 1-3.
European commission (1999-2002) project summaries 2nd call, search training network, pp. 1-4.
Lenting et al., The Journal of Biological Chemistry 274(34): 23734-23739 (1999).
Lenting et al., The Journal of Biological Chemistry 271(4): 1935-1940 (1996).
Yakhyaev et al., Blood 90(10)(suppl 1): 126 (abstract) (1997).
Eaton et al., Biochemistry 25(26): 8343-8347 (1986).
Liu et al., Blood 96(3): 979-987 (2000).
Pipe et al., Journal of Biological Chemistry 271(41): 25671-25676 (1996).
Schwarz et al., Blood 95(5): 1703-1708 (2000).
Willnow et al., Nature Cell Biology 1: E157-E162 (1999).
Lenting Petrus Johannes
Mertens Koenraad
Pannekoek Hans
Scheiflinger Friedrich
Schwarz Hans-Peter
Carlson Karen Cochrane
Liu Samuel W.
Proskauer Rose LLP
Stichting Sanquin Bloedvoorziening
LandOfFree
Factor VIII polypeptide having factor VIII:C activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor VIII polypeptide having factor VIII:C activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor VIII polypeptide having factor VIII:C activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073305